**Specifications Table**TableOrganism/cell line/tissue*Mus Musculus/Lung*Sequencer or array type*Agilent-028005 SurePrint G3 Mouse GE 8×60K Microarray*Data format*Raw: TXT files; normalized data: TXT files*Experimental factors*Exposures to a variety of nanomaterials (nano-titanium dioxide, carbon black, carbon nanotubes)*Experimental features*Bi-cluster analysis on publically available data obtained from Gene Expression Omnibus (GEO) describing specific lung diseases was conducted to identify functionally related gene sets. DAVID analysis was conducted on each of the gene sets from this analysis to identify functional representation of each gene set. Gene set enrichment analysis was then conducted on nine toxicogenomic gene expression studies examining the toxicity induced by a variety of nanomaterials to determine the disease significance of the altered gene expression profiles following exposure to NMs.*Sample source location*Ottawa, Ontario, Canada*Data accessibility*National Centre for Biotechnology Information, GEO database Accession:*[GSE35193](ncbi-geo:GSE35193){#ir0115}, [GSE41041](ncbi-geo:GSE41041){#ir0120}, [GSE47000](ncbi-geo:GSE47000){#ir0125}, [GSE60801](ncbi-geo:GSE60801){#ir0130}, [GSE61366](ncbi-geo:GSE61366){#ir0135}

**Value of the data**•The results enabled deeper mechanistic understanding of NM-induced lung toxicity.•The data enabled the development of a database with toxicity fingerprints that are specific to lung diseases.•Using the statistical tools and algorithms established, it may be possible to predict the toxicities of new NMs that have yet to undergo experimental testing.•The data was integral in identifying new gene sets associated with lung pathology that were previously not known.•The gene sets identified could serve as features for clustering and classifying NMs of diverse properties.

1. Data description {#s0005}
===================

We anticipate that the importance of toxicogenomics studies in chemical risk assessment will continue to increase in the coming years. However, its success will depend on 1) accurate and prompt reporting of the data, 2) ensuring public availability of the datasets and 3) sharing of the training sets and tools such as those described here. As the public repository of toxicogenomics datasets for individual NMs is populated, and the underlying mechanisms of NM-induced toxicity are revealed, the data can be used for routine categorization of NMs and their prioritization for further testing.

2. Experimental design, materials and methods {#s0010}
=============================================

2.1. Experimental design {#s0015}
------------------------

The discovery phase was the first step in this study. This involved obtaining publically available data from Gene Expression Omnibus (GEO) describing specific mouse lung diseases. Raw data files were downloaded and processed, normalized and standardized to the control samples. The data from these studies were then merged together and bi-cluster analysis was then conducted. [Fig. 1](#f0005){ref-type="fig"} outlines the various processing steps taken for the gene set discovery phase of the analysis.Fig. 1Workflow employed for the discovery phase of the analysis.Fig. 1

DAVID Analysis was then conducted on each of the bi-cluster to interpret the possible functions of the gene set. Gene set enrichment analysis was then conducted using the bi-clusters on a series of toxicogenomics studies on three NMs (nano-TiO2, CB and CNTs) to determine the disease significance of these data-driven gene sets. The specific details of these analyses are outlined below.

2.2. Lung disease models {#s0020}
------------------------

The data used in the discovery phase of novel gene sets relating to lung disease models and lung injury outcomes were obtained from the GEO. The accession numbers for these studies [@bib2], [@bib3], [@bib4], [@bib5], [@bib6], [@bib7], [@bib8], [@bib9], [@bib10], [@bib11], [@bib12], [@bib13] are presented in [Table 1](#t0005){ref-type="table"}. Lung disease models or lung injury outcomes addressed in this analysis included lung inflammation, emphysema, chronic obstructive pulmonary disease, and lung cancer and tumors. These studies utilized several different microarray platforms including the Affymetrix GeneChip®, and Illumina Expression Beadchip.Table 1Studies used for Gene Set Exploration Phase.Table 1Geo accessionPhenotype/modelMicroarray platform (GEO GPL ID)Reference[GSE4231](astm:GSE4231){#ir0010}Lung inflammationUCSF 10Mm Mouse v.2 Oligo Array (GPL1089); UCSF GS Operon Mouse v.2 Oligo Array (GPL3330); UCSF 11Mm Mouse v.2 Oligo Array (GPL3331); UCSF 7Mm Mouse v.2 Oligo Array (GPL3359)[@bib2][GSE6116](astm:GSE6116){#ir0015}Lung tumorsAffymetrix Mouse Genome 430 2.0 Array (GPL1261)[@bib3][GSE6858](astm:GSE6858){#ir0020}AsthmaAffymetrix Mouse Genome 430 2.0 Array (GPL1261)[@bib4][GSE8790](astm:GSE8790){#ir0025}EmphysemaAffymetrix Mouse Genome 430 2.0 Array (GPL1261)[@bib5][GSE11037](ncbi-geo:GSE11037){#ir0030}EmphysemaAgilent-011978 Mouse Microarray G4121A (GPL891)[@bib6][GSE18534](ncbi-geo:GSE18534){#ir0035}Small cell lung cancerAffymetrix Mouse Genome 430 2.0 Array (GPL1261)[@bib7][GSE19605](ncbi-geo:GSE19605){#ir0040}Lung carcinogenesisIllumina MouseRef-8 v2.0 Expression Beadchip (GPL6885)[@bib8][GSE25640](ncbi-geo:GSE25640){#ir0045}Pulmonary fibrosisAffymetrix Mouse Genome 430 2.0 Array (GPL1261)[@bib9][GSE31013](ncbi-geo:GSE31013){#ir0050}Spontaneous lung tumorsAffymetrix Mouse Genome 430 2.0 Array (GPL1261)[@bib10][GSE40151](ncbi-geo:GSE40151){#ir0055}Idiopathic pulmonary fibrosisAffymetrix Mouse Genome 430 2.0 Array (GPL1261)[@bib11][GSE42233](ncbi-geo:GSE42233){#ir0060}Lung cancerIllumina Mouse WG-6 v2.0 expression beadchip (GPL6887)[@bib12][GSE52509](ncbi-geo:GSE52509){#ir0065}Chronic obstructive pulmonary disease (COPD)Illumina MouseRef-8 v2.0 Expression Beadchip (GPL6885)[@bib13]

2.3. Data processing and normalization {#s0025}
--------------------------------------

The log2 transformation was applied to all signal intensity measurements. For the two colour microarray studies, the LOWESS normalization method [@bib14] using the R statistical software environment [@bib15] was applied. For studies using the Affymetrix GeneChips®, the RMA normalization was applied using the justRMA()function in the affy R package [@bib16]. Quantile normalization was applied for studies that utilized the Illumina Expression Beadchip and completed using the lumiN()function in the lumi R package [@bib17].

Probes with technical replicates were averaged using the median; the data for each study was then merged to its appropriate annotation file to obtain the gene symbol and probes with the same gene symbol were averaged using the median. Experimental conditions with biological replicates were also averaged using the median. The average for each of the experimental conditions was normalized to the appropriate control samples resulting in the log2 fold change for each experimental condition. The control samples were then removed from further analysis. All studies were merged together using the gene symbol. The resulting dataset consisted of 8752 gene symbols.

2.4. Bi-clustering {#s0030}
------------------

The bi-clustering data analysis was conducted in R using the biclust package [@bib18]. The Bimax method [@bib19] was selected for this analysis. Bimax uses a simple data model that assumes two possible states for each expression level, no change and change with respect to a control experiment. For this analysis, two binary matrices were constructed. One matrix representing zero\'s and one\'s where the one\'s indicate genes that were 2-fold up regulated and the second matrix where the one\'s identify genes that were 2-fold down regulated. These two matrices were analyzed independently.

The option for the minimum number of rows for the Bimax method was set at 15 and the minimum number of columns (which represent the experimental conditions) was set at 5 with the maximum number of columns set at 15. This resulted in 8 bi-clusters from the binary matrix representing the up regulated genes and 2 bi-clusters were identified for the matrix representing the down regulated genes.

2.5. DAVID analysis {#s0035}
-------------------

Gene lists from each bi-cluster were submitted to DAVID (<https://david-d.ncifcrf.gov/>) for functional annotation [@bib20], [@bib21]. Gene lists were pasted into the web application and the "Official_Gene_Symbol" was selected as the gene identifier. Mus Musculus was selected as the species which was used as the background for the analysis. Default settings were selected and used for the functional annotation clustering.

2.6. NM-induced lung response data sets {#s0040}
---------------------------------------

Datasets examining differential gene expression in mouse lung exposed to nano-titanium dioxide, carbon black or carbon nanotubes (nano-TiO2, CB and CNTs) were compiled from GEO. The GEO accession numbers for these studies are presented in [Table 2](#t0010){ref-type="table"}. These studies utilized the two-colour Agilent microarray (GPL7202 Agilent-014868 Whole Mouse Genome Microarray 4×44K G4122F and [GPL10787](ncbi-geo:GPL10787){#ir0145} Agilent-028005 SurePrint G3 Mouse GE 8×60K Microarray for [GSE61366](ncbi-geo:GSE61366){#ir0150}) reference design [@bib22]. The data were LOWESS normalized and probes with technical replicates were averaged. The annotation file containing the gene symbol was merged with the expression data and probes with multiple gene symbols were averaged using the median expression.Table 2NM Studies used for the Gene Set Enrichment Analysis.Table 2Geo AccessionNanomaterialDosesTime PointsReference[GSE29042](ncbi-geo:GSE29042){#ir0070}CNT: MWCNT-710 µg, 20 µg, 40 µg and 80 µg1, 3, 28 and 56 days[@bib23], [@bib24], [@bib25], [@bib26][GSE35193](ncbi-geo:GSE35193){#ir0075}CB: Printex 9018 µg, 54 µg and 162 µg1, 3 and 28 days[@bib27][GSE41041](ncbi-geo:GSE41041){#ir0080}TiO2: UV-Titan L18118 µg, 54 µg and 162 µg1, 3 and 28 days[@bib28][GSE47000](ncbi-geo:GSE47000){#ir0085}CNT: Mitsui718 µg, 54 µg and 162 µg1 and 28 days[@bib29][GSE60801](ncbi-geo:GSE60801){#ir0090}TiO2: NRCWE-025, NRCWE-03018 µg, 54 µg and 162 µg1, 3 and 28 days[@bib30][GSE60801](ncbi-geo:GSE60801){#ir0095}TiO2 Sanding dust: Indoor-R, IndoornanoTiO218 µg, 54 µg and 162 µg1 and 28 days[@bib31][GSE60801](ncbi-geo:GSE60801){#ir0100}TiO2: Sanding dust NRCWE-032, Sanding dust NRCWE-03318 µg, 54 µg and 162 µg1 and 28 days[@bib31][GSE60801](ncbi-geo:GSE60801){#ir0105}TiO2: NRCWE 001 (neutral), NRCWE 002 (positively charged)18 µg, 54 µg and 162 µg1 and 28 days[@bib31][GSE61366](ncbi-geo:GSE61366){#ir0110}CNT: NRCWE-26, NM-40118 µg, 54 µg and 162 µg1, 3 and 28 days[@bib31]

2.7. Gene set enrichment {#s0045}
------------------------

As the NM-induced lung response data sets contained multiple doses, the test statistic from the Attract approach was used [@bib32]. Using this method, the overall F-statistic for the dose effect was estimated for each gene. Since large F-statistics are indicative of a strong dose effect, a bi-cluster whose distribution of F-statistics is skewed towards larger values represents an enrichment of that gene set. A two sample t-test assuming unequal variances was then conducted comparing the mean of the log2 F-statistics within the bi-cluster to the mean of the log2 F-statistics for all genes. For bi-cluster 7, a graphical representation of the group medians for [GSE61366](ncbi-geo:GSE61366){#ir0155} is presented as [Fig. 2](#f0010){ref-type="fig"}. The p-values for NRCWE-26 were 0.6091, 0.0412 and \< 0.0001 for days 1, 3, and 28 and similarly for NM-401 with p-values of 0.5391, 0.0005 and \< 0.0001. These results were graphically reported in Williams and Halappanavar [@bib1].Fig. 2A heatmap of Bi-cluster 7 for [GSE61366](astm:GSE61366){#ir0005} is presented. Biological replicates were averaged using the median. Group medians were clustered using average linkage with the 1-correlation dissimilarity metric estimated using spearman correlations.Fig. 2

The results identified all the NMs to be inflammogenic and only CB and CNTs as potentially fibrogenic. In addition to identifying several previously defined, functionally relevant gene sets, the study also identified two novel genes associated with pulmonary fibrosis and reactive oxygen species. These results demonstrate the advantages of using a data-driven approach to identify novel, functionally related gene sets.

Transparency document. Supplementary material {#s0055}
=============================================

Transparency document

Appendix A. Supplementary material {#s0065}
==================================

1\. RCode RMA normalization.R. 2. RCode Quantile normalization.R. 3. RCode LOWESS normalization.R. 4. RCode Cyclic LOWESS normalization. 5. RCode Merging biclust Bimax analysis.R. 6. RCode NMs GSEA on bi-clusters.R. 7. All Data.zip.
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